Product logins

Find logins to all Clarivate products below.


Rick Finch

Senior Vice President, Life Sciences and Healthcare

As Global Lead for Clarivate Life Sciences and Healthcare Consulting Services, Rick is responsible for trusted partnerships and customer success across all practice areas, including Discovery and Translational Sciences, Clinical and Regulatory, Market Access, New Product Planning, Commercial Strategy, HEOR and Technology Services.​

His focus is on helping executives improve decision making and accelerate execution in the areas of early stage scientific research, drug development, and commercialization. ​

Over the past 20+ years, Rick has worked with major pharmaceutical, digital advertising, high-tech, consumer goods and retail companies in areas such as product research and development, sales and marketing, operations, and information technology. During that time, he has led key transformation programs in analytics and data management, post-merger integration, product launch and support, new product development, digital sales and marketing, customer/patient centricity, and technology enablement.​

Prior to joining Clarivate in 2019, Rick was a Managing Director at Accenture, leading the sales and marketing consulting practice across Life Sciences, Consumer Goods and Retail. Rick has an M.Phil from the University of Oxford and a B.A. in History from Boston College.


arrow_forward
Get in touch with Rick

Related resources

支付方愿意为便利性买单的市场准入“最佳切入点” 支付方愿意为便利性买单的市场准入“最佳切入点”
Blog June 3, 2026
支付方愿意为便利性买单的市场准入“最佳切入点”
医疗保险 定价 市场准入 真实世界数据 美国市场 药政法规
2026 年值得关注的 5 大医疗技术趋势 2026 年值得关注的 5 大医疗技术趋势
Blog May 28, 2026
2026 年值得关注的 5 大医疗技术趋势
AI/机器学习 GLP-1 医疗技术 带量采购(VBP) 日间手术中心(ASC)
《2026年最值得关注的药物》问答:礼来的下一代减肥药 《2026年最值得关注的药物》问答:礼来的下一代减肥药
Blog March 26, 2026
《2026年最值得关注的药物》问答:礼来的下一代减肥药
GLP-1 最值得关注的药物
为何长寿研究可能成为生物制药的下一个风口:当科学与商业的交汇 为何长寿研究可能成为生物制药的下一个风口:当科学与商业的交汇
Blog March 2, 2026
为何长寿研究可能成为生物制药的下一个风口:当科学与商业的交汇
AI/机器学习 GLP-1 临床试验 交易 药政法规 衰老生物学